CLINICAL TRIALS PROFILE FOR LORTAB

All Clinical Trials for LORTAB

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00174538 ↗	Codeine in Sickle Cell Disease	Completed	PriCara, Unit of Ortho-McNeil, Inc.	Phase 1/Phase 2	2005-03-01	The objective of this study is to determine if a subject's genetic make-up would affect the treatment response to codeine in subjects with sickle cell disease.
NCT00385684 ↗	Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)	Completed	VA Office of Research and Development	Phase 4	2007-10-01	The purpose of this study was to determine whether a low dose an opiate pain medication is effective for the treatment of discomfort in patients with advanced dementia. The study medication was also known as Lortab and contained both a narcotic pain medication and acetaminophen (the same pain medication as contained in Tylenol). This study was an eight-week long clinical trial for discomfort among veterans with advanced dementia who were admitted to a Nursing Home Care Unit (NHCU) at the Tuscaloosa VA Medical Center.
NCT00574015 ↗	The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache	Completed	Albany Medical College	Phase 4	2007-12-01	This study will compare the degree of pain control provided by two techniques for persons with toothache in an emergency department. The two techniques include; - standard oral narcotic pain medication - numbing the tooth with local anesthetic by needle injection
NCT00583453 ↗	Celecoxib as a Post-tonsillectomy Pain Medication	Completed	Pfizer	Phase 2	2007-10-01	The hypothesis is that celecoxib effectively reduces pain after a tonsillectomy and reduces post-operative narcotic use. To test this hypothesis, the study is placebo controlled (sugar pill). Half of the participants will receive a sugar pill, half will not. All participants will receive the standard post-operative pain medications. We ask participants to log the amount of medications they use daily, and the amount of pain they have each day. It is hoped that celecoxib will reduce the amount of post-operative pain medication needed.
NCT00583453 ↗	Celecoxib as a Post-tonsillectomy Pain Medication	Completed	University of Iowa	Phase 2	2007-10-01	The hypothesis is that celecoxib effectively reduces pain after a tonsillectomy and reduces post-operative narcotic use. To test this hypothesis, the study is placebo controlled (sugar pill). Half of the participants will receive a sugar pill, half will not. All participants will receive the standard post-operative pain medications. We ask participants to log the amount of medications they use daily, and the amount of pain they have each day. It is hoped that celecoxib will reduce the amount of post-operative pain medication needed.

Clinical Trial Conditions for LORTAB

Condition Name

Condition Name for LORTAB
Intervention	Trials
Pain, Postoperative	4
Pain	2
Recurrent Tonsillitis	1
Mucositis	1

Condition MeSH

Condition MeSH for LORTAB
Intervention	Trials
Pain, Postoperative	4
Tonsillitis	2
Fractures, Bone	2
Sleep Apnea Syndromes	1

Clinical Trial Locations for LORTAB

Trials by Country

Trials by Country for LORTAB
Location	Trials
United States	16

Trials by US State

Trials by US State for LORTAB
Location	Trials
Tennessee	3
Texas	2
New York	2
California	1
Georgia	1

Clinical Trial Progress for LORTAB

Clinical Trial Phase

Clinical Trial Phase for LORTAB
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	1
Phase 2	3

Clinical Trial Status

Clinical Trial Status for LORTAB
Clinical Trial Phase	Trials
Completed	9
Terminated	3
Enrolling by invitation	1

Clinical Trial Sponsors for LORTAB

Sponsor Name

Sponsor Name for LORTAB
Sponsor	Trials
Baylor College of Medicine	2
Emory University	1
VA Office of Research and Development	1

Sponsor Type

Sponsor Type for LORTAB
Sponsor	Trials
Other	15
Industry	3
U.S. Fed	1